These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 16430624)
21. Surgical margin status of open versus laparoscopic radical prostatectomy specimens. Terakawa T; Miyake H; Tanaka K; Takenaka A; Inoue TA; Fujisawa M Int J Urol; 2008 Aug; 15(8):704-7; discussion 708. PubMed ID: 18462349 [TBL] [Abstract][Full Text] [Related]
22. Radical prostatectomy for high-risk prostate cancer: biochemical outcome. Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167 [TBL] [Abstract][Full Text] [Related]
23. The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapy. Davis BJ; Pisansky TM; Wilson TM; Rothenberg HJ; Pacelli A; Hillman DW; Sargent DJ; Bostwick DG Cancer; 1999 Jun; 85(12):2630-7. PubMed ID: 10375112 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of modern pathological criteria for positive margins in radical prostatectomy specimens and their use for predicting biochemical recurrence. Bong GW; Ritenour CW; Osunkoya AO; Smith MT; Keane TE BJU Int; 2009 Feb; 103(3):327-31. PubMed ID: 19007381 [TBL] [Abstract][Full Text] [Related]
25. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database. Scales CD; Presti JC; Kane CJ; Terris MK; Aronson WJ; Amling CL; Freedland SJ; J Urol; 2007 Oct; 178(4 Pt 1):1249-52. PubMed ID: 17698131 [TBL] [Abstract][Full Text] [Related]
26. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? Tareen B; Godoy G; Sankin A; Temkin S; Lepor H; Taneja SS BJU Int; 2009 Jul; 104(2):195-9. PubMed ID: 19191784 [TBL] [Abstract][Full Text] [Related]
27. Impact of patient age on biochemical recurrence rates following radical prostatectomy. Magheli A; Rais-Bahrami S; Humphreys EB; Peck HJ; Trock BJ; Gonzalgo ML J Urol; 2007 Nov; 178(5):1933-7; discussion 1937-8. PubMed ID: 17868723 [TBL] [Abstract][Full Text] [Related]
28. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy. Villamón-Fort R; Martínez-Jabaloyas JM; Soriano-Sarriá P; Ramos-Soler D; Pastor-Hernández F; Gil-Salom M Urol Int; 2007; 78(4):328-33. PubMed ID: 17495491 [TBL] [Abstract][Full Text] [Related]
29. [Location of extraprostatic extension and positive surgical margin in radical prostatectomy specimens]. Sakamoto N; Kagawa Y; Tanaka S; Iguchi A; Hasegawa Y; Koga H; Naito S Nihon Hinyokika Gakkai Zasshi; 2004 Jan; 95(1):42-9. PubMed ID: 14978940 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of pT2 subdivisions in the TNM staging system for prostate cancer. Hong SK; Han BK; Chung JS; Park DS; Jeong SJ; Byun SS; Choe G; Lee SE BJU Int; 2008 Nov; 102(9):1092-6. PubMed ID: 18671786 [TBL] [Abstract][Full Text] [Related]
32. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy. Suekane S; Noguchi M; Nakashima O; Yamada S; Kojiro M; Matsuoka K Int J Urol; 2007 Aug; 14(8):713-8. PubMed ID: 17681061 [TBL] [Abstract][Full Text] [Related]
33. Pathologic outcome of laparoscopic and open radical prostatectomy. Dahl DM; He W; Lazarus R; McDougal WS; Wu CL Urology; 2006 Dec; 68(6):1253-6. PubMed ID: 17141845 [TBL] [Abstract][Full Text] [Related]
34. The maximum tumour length in biopsy cores as a predictor of outcome after radical prostatectomy. Hayashi N; Urashima M; Kuruma H; Arai Y; Kuwao S; Iwamura M; Egawa S BJU Int; 2008 Jan; 101(2):175-80. PubMed ID: 17850362 [TBL] [Abstract][Full Text] [Related]
35. Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers. Boorjian SA; Karnes RJ; Rangel LJ; Bergstralh EJ; Frank I; Blute ML BJU Int; 2008 Feb; 101(3):299-304. PubMed ID: 17922854 [TBL] [Abstract][Full Text] [Related]
36. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. Nelson BA; Shappell SB; Chang SS; Wells N; Farnham SB; Smith JA; Cookson MS BJU Int; 2006 Jun; 97(6):1169-72. PubMed ID: 16686706 [TBL] [Abstract][Full Text] [Related]
37. Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens. Park EA; Lee HJ; Kim KG; Kim SH; Lee SE; Choe GY Int J Urol; 2007 Aug; 14(8):704-8. PubMed ID: 17681059 [TBL] [Abstract][Full Text] [Related]
38. Clinical staging error in prostate cancer: localization and relevance of undetected tumour areas. Bolenz C; Gierth M; Grobholz R; Köpke T; Semjonow A; Weiss C; Alken P; Michel MS; Trojan L BJU Int; 2009 May; 103(9):1184-9. PubMed ID: 19154463 [TBL] [Abstract][Full Text] [Related]
39. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression? Pfitzenmaier J; Pahernik S; Tremmel T; Haferkamp A; Buse S; Hohenfellner M BJU Int; 2008 Nov; 102(10):1413-8. PubMed ID: 18537951 [TBL] [Abstract][Full Text] [Related]
40. High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy. Pierorazio PM; Lambert SM; Matsukhani M; Sprenkle PC; McCann TR; Katz AE; Olsson CA; Benson MC; McKiernan JM BJU Int; 2007 Nov; 100(5):1066-70. PubMed ID: 17784880 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]